![](https://www.theradaptive.com/wp-content/uploads/2023/06/Theradaptive.jpg)
U.S. FDA Grants Theradaptive IDE Approval For Phase I/II Clinical Trials
February 22, 2024
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2023/08/Untitled-500-×-300-px.png)
3D Systems & Theradaptive Establish Commercial Partnership to Advance Orthopedic & Soft Tissue Repair Using Breakthrough Regenerative Therapeutics
August 8, 2023
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2023/07/BPI_logo.jpg)
Leveraging Material-Binding Recombinant Proteins: A Novel Approach to Tissue Regeneration
April 20, 2023
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2023/07/download.png)
Unlocking a New Era of Healing: Protein Engineering’s Transformative Impact on Therapeutics – BioTalk
April 3, 2023
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2023/02/Theradaptive-Image.png)
U.S. Department of Defense Awards Theradaptive $4 Million Contract for Its OsteoAdapt Regenerative Therapeutic Program
March 1, 2023
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2023/02/706_main.jpg)
Revolutionizing Orthopedics: The Transformative Potential of Regenerative Medicine
February 23, 2023
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2023/02/Picture10.png)
Theradaptive’s Targetable Protein AMP2 Beats Spinal Fusion Standard of Care
February 9, 2023
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2022/10/Luis_1-scaled.jpg)
Why Protein Engineering Is Opening Up New Horizons for Medical Devices By Dr Luis Alvarez
October 26, 2022
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2023/02/Theradaptive-Image.png)
Theradaptive Wins Additional FDA Breakthrough Designation for Spinal Fusion
February 15, 2022
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2023/02/Theradaptive-Image.png)
Theradaptive closes seed round bringing total investment to $17.4M to date.
January 19, 2021
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2023/02/Theradaptive-Image.png)
Theradaptive, Inc. Receives $6.2 Million Infusion of Cash from Seed Funding
January 19, 2021
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2023/02/Theradaptive-Image.png)
Governor Hogan announced Maryland’s Future 20, a list of innovative startups. #USAMRDC licensing partner, Theradaptive Inc is among the five life science companies chosen for the list.
January 14, 2021
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2023/02/Theradaptive-Image.png)
Frederick biotech Theradaptive raises $6.2M as it heads toward clinical trials
January 14, 2021
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2020/12/rf-logo.png)
Recon: US buys another 100M doses of Pfizer-BioNTech vaccine; AstraZeneca submits vaccine data to MHRA
December 23, 2020
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2020/09/09834-feature4-gates.jpg)
Career Ladder: Luis Alvarez West Point and MIT grad brings his love of chemistry to bear on regenerative medicine
September 1, 2020
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2020/08/cropped-BioBuzz-Horizontal-Logo-e1602000773133.webp)
These Seed and Early-Stage Investment Funds in Maryland Are Fueling Life Science Startups
August 19, 2020
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2020/04/rebossis.jpg)
A Sticky Solution to a Hard Problem : Interview with Dr. Luis Alvarez, CEO of Theradaptive
April 6, 2020
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2020/02/download.png)
Army veteran’s bone ‘paint’ for wounded warriors nears FDA testing phase
February 20, 2020
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2020/02/medics-simulated-injury-rangers-1800.jpg)
‘Paint’ that Purports to Regrow Wounded Troops’ Bones Moving Toward FDA Testing
February 20, 2020
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2023/02/Theradaptive-Image.png)
The Alliance for Regenerative Medicine Releases Agenda for 2020 Cell & Gene Meeting on the Mediterranean
February 13, 2020
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2023/02/Theradaptive-Image.png)
ORTHOREBIRTH and Theradaptive Enter into License Agreement for THX-14, a Regenerative Treatment Candidate for Trauma with option to extend into Spine Fusion
December 11, 2019
READ MORE
![](https://www.theradaptive.com/wp-content/uploads/2023/02/Theradaptive-Image.png)
Theradaptive Selected as a Finalist at the 2018 First Coast Innovation Challenge in Boston
April 23, 2019
READ MORE